Dae-Kee Kim Selected Research

Dae-Kee Kim Research Topics

Disease

19	Neoplasms (Cancer) 06/2023 - 01/2003
11	Breast Neoplasms (Breast Cancer) 11/2015 - 05/2004
10	Fibrosis (Cirrhosis) 01/2023 - 07/2011
6	Neoplasm Metastasis (Metastasis) 06/2023 - 10/2011
3	Hyperplasia 05/2013 - 04/2010
3	Stomach Neoplasms (Stomach Cancer) 12/2012 - 10/2002
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 01/2016
2	Non-alcoholic Fatty Liver Disease 01/2023 - 01/2022
2	Inflammation (Inflammations) 01/2022 - 11/2007
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 05/2015 - 07/2011
2	Hepatocellular Carcinoma (Hepatoma) 12/2008 - 04/2004
2	Erectile Dysfunction 09/2007 - 08/2007
1	Adenocarcinoma 06/2023
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2023
1	Fatty Liver 01/2023
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022
1	Pathologic Constriction (Stenosis) 07/2017
1	Leukemia 02/2016
1	Ureteral Obstruction 05/2015
1	Melanoma (Melanoma, Malignant) 11/2013
1	Experimental Melanoma 11/2013
1	Necrosis 03/2013
1	Penile Induration (Peyronie's Disease) 05/2009
1	Pulmonary Hypertension 02/2009
1	Hypoxia (Hypoxemia) 02/2009
1	Right Ventricular Hypertrophy 02/2009
1	Vascular Remodeling 02/2009
1	Pulmonary Arterial Hypertension 02/2009
1	Prostatic Neoplasms (Prostate Cancer) 12/2008
1	Encephalomyelitis (Myeloencephalitis) 11/2007
1	Paralysis (Palsy) 11/2007

Drug/Important Bio-Agent (IBA)

10	Phosphotransferases (Kinase)IBA 06/2023 - 05/2009
9	vactosertibIBA 06/2023 - 11/2013
8	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2023 - 02/2009
7	Activin Receptors (Activin Receptor)IBA 11/2013 - 12/2008
7	Histone Deacetylase InhibitorsIBA 05/2012 - 05/2004
6	Histone Deacetylases (Histone Deacetylase)IBA 01/2012 - 12/2003
5	CollagenIBA 06/2023 - 07/2017
4	3- ((5- (6- methylpyridin- 2- yl)- 4- (quinoxalin- 6- yl)- 1H- imidazol- 2- yl)methyl)benzamideIBA 08/2014 - 12/2008
4	3- (4- dimethylaminophenyl)- N- hydroxy- 2- propenamideIBA 05/2012 - 05/2006
4	Estrogen ReceptorsIBA 05/2012 - 05/2004
4	3- ((4- (6- methylpyridin- 2- yl)- 5- (quinolin- 6- yl)- 1H- imidazol- 2- yl)methyl)benzamideIBA 09/2011 - 02/2009
4	Transforming Growth Factor beta (TGF-beta)IBA 07/2011 - 11/2007
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 01/2022
2	Therapeutic UsesIBA 11/2015 - 11/2013
2	CyclinsIBA 01/2012 - 08/2004
2	benzonitrileIBA 11/2011 - 10/2011
2	Transforming Growth Factor beta1 (TGF beta 1)IBA 05/2009 - 11/2007
2	Transforming Growth Factor-beta Type I ReceptorIBA 05/2009 - 12/2008
2	SK-7068IBA 01/2008 - 08/2004
2	Histones (Histone)IBA 05/2006 - 04/2004
2	HC toxinIBA 06/2004 - 05/2004
2	trichostatin A (A 300)IBA 06/2004 - 05/2004
2	Complementary DNA (cDNA)IBA 01/2003 - 10/2002
2	AntigensIBA 01/2003 - 10/2002
1	Fibronectins (Fibronectin)IBA 06/2023
1	Gemcitabine FDA Link 06/2023
1	Drug CombinationsIBA 01/2023
1	AMP-Activated Protein KinasesIBA 01/2023
1	CurcuminIBA 01/2023
1	AcidsIBA 01/2022
1	EstersIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 02/2016
1	Paclitaxel (Taxol)FDA LinkGeneric 11/2015
1	Bleomycin (Blenoxane)FDA LinkGeneric 05/2015
1	Carbon Tetrachloride (Tetrachloromethane)IBA 05/2015
1	LY-2157299IBA 11/2013
1	UbiquitinIBA 11/2013
1	Smad4 ProteinIBA 11/2013
1	A 62176IBA 12/2012
1	Cyclin D1IBA 12/2012
1	Estrogen Receptor Modulators (Antiestrogen)IBA 05/2012
1	EnzymesIBA 01/2012
1	Apoptosis Regulatory ProteinsIBA 01/2012
1	Thymidylate SynthaseIBA 01/2012
1	Hormones (Hormone)IBA 01/2012
1	3- ((4- ((1,2,4)triazolo(1,5- a)pyridin- 6- yl)- 5- (6- methylpyridin- 2- yl)- 1H- imidazol- 2- yl)methylamino)benzonitrileIBA 11/2011
1	3- ((5- ((1,2,4)triazolo(1,5- a)pyridin- 6- yl)- 4- (6- methylpyridin- 2- yl)thiazol- 2- ylamino)methyl)benzonitrileIBA 10/2011
1	Environmental Pollutants (Pollutants, Environmental)IBA 07/2011
1	Proteins (Proteins, Gene)FDA Link 07/2011
1	CytokinesIBA 07/2011
1	OzoneIBA 07/2011
1	Plasminogen Activator Inhibitor 1IBA 07/2011
1	MonocrotalineIBA 02/2009
1	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 02/2009
1	Aurora Kinase AIBA 01/2008
1	LAQ824IBA 01/2008
1	PiperazineIBA 09/2007
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 09/2007
1	2- (5- (4- (2- hydroxyethyl)piperazin- 1- ylsulfonyl)- 2- n- propoxyphenyl)- 5- ethyl- 7- n- propyl- 3,5- dihydro- 4H- pyrrolo(3,2- d)pyrimidin- 4- one dihydrochlorideIBA 09/2007
1	Phosphodiesterase 5 InhibitorsIBA 08/2007
1	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 08/2007
1	Sildenafil Citrate (Viagra)FDA Link 08/2007
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 08/2004
1	SK-7041IBA 08/2004

Therapy/Procedure

4	Stents 07/2017 - 04/2010
4	Therapeutics 11/2015 - 05/2012
2	Ligation 01/2016 - 05/2015
1	Drug Therapy (Chemotherapy) 11/2015
1	Intraperitoneal Injections 07/2011